Second-Line Systemic Treatment for Metastatic Urothelial Carcinoma: A Network Meta-Analysis of Randomized Phase III Clinical Trials

Second-Line Systemic Treatment for Metastatic Urothelial Carcinoma: A Network Meta-Analysis of Randomized Phase III Clinical Trials

Purpose: We aimed to evaluate and compare relative impacts of various second-line treatments on overall survival (OS) in metastatic urothelial carcinoma (mUC).Method: A literature search was conducted in PubMed, Embase, and the Cochrane Library for all articles published prior to December 2018 in ac...

Full description

Bibliographic Details
Main Authors: Hyun Sik Yoon, Cheol Kwak, Hyeon Hoe Kim, Hyung Suk Kim, Ja Hyeon Ku
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-07-01
Series:Frontiers in Oncology
Subjects:
carcinoma
transitional cell
chemotherapy
immunotherapy
survival
network meta-analysis
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2019.00679/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2019.00679/full

Similar Items